30-Second Takeaway
- ESPB gives modest early pain and recovery benefits after median sternotomy but effects vary by center.
- Systemic prophylactic IV antibacterials probably reduce VAP incidence in ventilated ICU patients.
Week ending June 6, 2026
Selected 2026 evidence briefs relevant to cardiothoracic surgical practice
Protocol: AI-assisted education versus SMS in older postoperative head-and-neck cancer patients
This single-center RCT protocol will randomize 100 postoperative head-and-neck cancer patients aged ≥60 to AI-assisted education (n=50) versus standardized SMS (n=50). Intervention delivers 12 months of personalized, phased content and real-time AI Q&A; outcomes include stress, QoL, nutrition, sleep, and mood at five timepoints to 12 months. Analysis plans intent-to-treat linear mixed models to estimate mental health and QoL effects and manage missing data. Generalisability is limited by single-center design and reliance on self-reported outcomes.
ESPB modestly reduces early pain and opioid use after median sternotomy
Meta-analysis of 19 RCTs (N=1344) found ESPB reduced 24‑hour pain after median sternotomy (MD -0.65; 95% CI -1.14 to -0.16). ESPB also lowered intraoperative and 24‑hour opioid consumption (MD about -80.8 mg and -45.8 mg OME), time to extubation (MD -1.28 h), and ICU stay (MD -13.1 h) in the sternotomy subgroup. Heterogeneity was very high and wide prediction intervals crossed the null, implying effects vary across centers. No consistent benefit was seen in minimally invasive cardiac surgery; certainty is low to very low for many outcomes.
Explainable XGBoost predicts textbook outcome after free flap oral cancer reconstruction
Single-center retrospective cohort (n=752) developed an XGBoost model predicting textbook outcome with AUC 0.843, accuracy 0.764, and sensitivity 0.733 in validation. Overall textbook outcome rate was 38.2%, and key predictors included albumin, age, operative time, T stage, and NLR. SHAP analyses suggested threshold effects at age >50, albumin >45 g/L, and operative time >400 minutes that may guide perioperative risk discussions. Model is internally validated only and requires external validation before clinical deployment.
References
Numbered in order of appearance. Click any reference to view details.
Additional Reads
Optional additional studies from this edition.